latest news on glp 1 drugs New analysis of GLP-1 suggests people who stopped using medications regained 60% of weight lost New oral GLP-1 drug delivers

One of the defining pathological features of AD is the intraneuronal accumulation of NFTs (35)

Consistent with these pathological findings, both semaglutide and tirzepatide significantly lowered liver triglycerides (TG) and total cholesterol (TC) (Fig.4-C, D)

One article found an increased incidence of aspiration pneumonia among GLP-1 users compared to non-users reporting a hazard ratio of 1.33 (95%CI 1.021.74, p = 0.036) (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)

Julius A, Hopper W

doi:10.1038/s41573-021-00337-8

Your provider can give you tips on the best way to administer the medication, and the drug manufacturers consumer websites typically have instructional videos and guides